CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses

In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).

In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).

respiratory syncytial virus

Sorry, no results found.

We tried our best, but we couldn't find any articles relating to .